8/31/09 am Mon Newsday Rejects Ads by Verizon, Now a Rival

Post #82 The following is brought to you by Intellivest Securities Research, Inc. The following is not intended as advertising by a broker-dealer and is not a research report. Towards the end of the Blog you will find an update of the Dow Jones 30 company recent filings.

A read of Monday's 8/31/09 print editions of: Wall Street Journal, Financial Times, New York Times, Investors Business Daily, Atl Journal Const, USA Today and Sept issue of AARP Bulletin yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by symbol and Tuesday's closing price and related data:

Dow: The Dow divisor at WSJ pC4 remains unchanged at 0.132319125. NYT B1 "Some Once-Bullish Analysts LSee an End to Market Rally" that asks if thestock market is ovepriced becasue stocks have risen 52% since reaching their March lows and said the Dow closed on Friday near its heighest levels of the year, up 45% from its March low.

AT&T T $26.21 -0.21 0.79% 21,997,644 NYSE: WSJ pC10 "eard on the Street - AT&T Gets a Fuzzy Signal on Apple's iPHone" says T's exclusive right to offer Apple's smart phone over the past 2 years has attracted enw customers and enhanced T's image but it is difficult to know whether those benefits are worth some considerable costs including regulators investigating exclusivity deals and only 40% of the 10 million activations of iphones sincd it became available in '07 were new customers.

AA $12.5 +0.10 0.81% 20,312,044 NYSE: No mentions found.

Amex AXP $34.24 +0.28 0.82% 10,696,189 NYSE: NYT pA1 "As BanksrepayBailout Money, US sees Profit - About $4 billion so Far" has a table of the returns made by the gov. as a result of the TARP bailout money which was used to buy warrants, AXP received $3.4bil, paid back $414 mil for a return of 23.4% to the gov, JPMorgan sold back its warrants for which the gov paid $25 Bil with a profit of $2 bil for a profit of 13.3% and Bofam hasn't paid back its $45 bil yet but on paper BAC owes the gov $14 bil for an annual yeild of 47%. Similar story at Fin Times p3.

Bank of Am BAC $17.98 +0.06 0.33% 187,222,689 NYSE: NYT pA1 "As BanksrepayBailout Money, US sees Profit - About $4 billion so Far" has a table of the returns made by the gov. as a result of the TARP bailout money which was used to buy warrants, AXP received $3.4bil, paid back $414 mil for a return of 23.4% to the gov, JPMorgan sold back its warrants for which the gov paid $25 Bil with a profit of $2 bil for a profit of 13.3% and Bofam hasn't paid back its $45 bil yet but on paper BAC owes the gov $14 bil for an annual yeild of 47%. Similar story at Fin Times p3.

Meanwhile, WSJ pA1 "Raft of Deals for Failed Banks Puts US on Hook for Billions" that says while the Treasury Dept's $700 billion Troubled Asset Relief Program went to big banks such as BAC, it was also buying up $80 billion in loans and other assets from other troubled banks that the US will lose money on.

AARP has a story "Scam Alert - Unsolicited offers can lead to big bills in your mailbox" focuses on an alleged Bank of America auto insurance program sold by a third party vendor that was deducting $18.95 each month from a 98 year old woman who didn't even own a car.

Boeing BA $51.04 -0.78 1.51% 11,450,057 NYSE: WSJ pC1, As Disposals Slow at AIG, ILFC Chief Makes Pitch" says the ehad of AIG's aircraft leasing business is in talks to buy a pice of the unit. Steven Udvar-Hazy, chairman and ceo of Linernational Lease Finance Ckorpo. is trying to buy about $2 bill of ILFC's aircraft portfolio. ILFC is the world's largest aircraft lessor by fleet value and the largest customer for both Boeing and Airbus. ILFC's attrachtion to buyers was the strength of management and a scale that is matched only by the Gecas unit of GE, that secured the best purchase price and terms from Airbus and BA. Similar story at Fin Times p11.

Caterpillar CAT $46.71 -0.37 0.79% 7,562,470 NYSE: WSJ pC10 "Drug managers Should Keep Their health" says that deals bdirect deals between large companeis and drug stores, such as Walgreen's and Caterpillar's, won't threaten pharmacy benefit managers because CAT will keep its benefit manager to handle rebate negotiations.

CVX $70.68 -0.32 0.45% 7,279,791 NYSE: No mentions found.

CSCO $22 +0.12 0.55% 35,876,840 NASDAQ-GS: No mentions found.

KO $49.06 -0.38 0.77% 6,826,159 NYSE: No mentions found.

DD $32.56 +0.23 0.71% 6,471,222 NYSE: No mentions found.

DIS $26.84 -0.17 0.63% 9,229,411 NYSE: No mentions found.

XOM $70.12 -0.74 1.04% 17,654,968 NYSE: No mentions found.

GE $14.08 -0.11 0.78% 73,570,478 NYSE: WSJ pB1 "Wind Farms Set Wall Street Aflutter" mentions GE's Energy Financial Services division which has been a major financie of financing wind farms.

WSJ pC1, As Disposals Slow at AIG, ILFC Chief Makes Pitch" says the ehad of AIG's aircraft leasing business is in talks to buy a pice of the unit. Steven Udvar-Hazy, chairman and ceo of Linernational Lease Finance Ckorpo. is trying to buy about $2 bill of ILFC's aircraft portfolio. ILFC is the world's largest aircraft lessor by fleet value and the largest customer for both Boeing and Airbus. ILFC's attrachtion to buyers was the strength of management and a scale that is matched only by the Gecas unit of GE, that secured the best purchase price and terms from Airbus and BA.Similar story at Fin Times p11.

HPQ $44.76 -0.05 0.11% 19,534,247 NYSE: No mentions found.

HD $27.69 +0.14 0.51% 12,806,127 NYSE: No mentions found.

Intel INTC $20.25 +0.78 4.01% 104,941,771 NASDAQ-GS: WSJ pC9, "Options Report - Intel Outlook Spurs Chip Activity - Bulls Place Their Bets on Advanced Micro Devices, SanDisk and Nvidia" says the options market played host to robust activity in chip makers on Fri. after INTC raised its forecast on third quarter sales.

IBD pA1 "Intel Hikes Outlook In The Latest Sign Of a Tech Reovery" says INTC's shares rose 4% to nearly a 52 week high although some urge caution.

IBM $118.22 -1.21 1.01% 6,209,889 NYSE: IBD pA5, "SAP Is Company At Crossroads As Huge Rivals Line Its Horizon" says Oracle, IBM and MSFT have aggressively built big platforms to attach SAP's market. Story says SAP may eventually be sold to a company such as IBM or MSFT.

JPMorgan Chase JPM $42.92 -0.53 1.22% 27,092,089 NYSE: NYT pA1 "As BanksrepayBailout Money, US sees Profit - About $4 billion so Far" has a table of the returns made by the gov. as a result of the TARP bailout money which was used to buy warrants, AXP received $3.4bil, paid back $414 mil for a return of 23.4% to the gov, JPMorgan sold back its warrants for which the gov paid $25 Bil with a profit of $2 bil for a profit of 13.3% and Bofam hasn't paid back its $45 bil yet but on paper BAC owes the gov $14 bil for an annual yeild of 47%. Similar story at Fin Times p3.

WSJ pB1 "Paper Owner Freedom Plans to File For Cahpter 11" says Freedom Communications Inc. the owner of the Orange county Register is expected to file bankruptcy this week. Its lenders hold $770 mil in debt and include JPMorgan Chase.

Johnson & Johnson JNJ $60.29 -0.20 0.33% 10,869,444 NYSE: WSJ pB2 "New Blood thinner Matches Warfarin" says a blood thinner being developed by Boehringer Ingleheim GmbH proved to be at lest as effective as the workhorse heart drug warfarin in a trial est that could help usher in a new era for stroke prevention for patients with atrial fibrillation. There are other companies trying to develop an altenative to warfarin which is marketed by Bristol-Myers Squibb as Coumadin and available in generic vesions. JNJ and Bayer's Xarelto is trying to find an product to rival warfarin; Bristol-Myers and Pfizer are codeveloping apixaban and Merck recently joined fores with Portola to develop betrixaban.
KFT $28.34 -0.08 0.28% 5,953,786 NYSE
MCD $56.07 -1.09 1.91% 8,662,629 NYSE

Merck MRK $32.32 -0.55 1.67% 12,049,972 NYSE: WSJ pB2 "New Blood thinner Matches Warfarin" says a blood thinner being developed by Boehringer Ingleheim GmbH proved to be at lest as effective as the workhorse heart drug warfarin in a trial est that could help usher in a new era for stroke prevention for patients with atrial fibrillation. There are other companies trying to develop an altenative to warfarin which is marketed by Bristol-Myers Squibb as Coumadin and available in generic vesions. JNJ and Bayer's Xarelto is trying to find an product to rival warfarin; Bristol-Myers and Pfizer are codeveloping apixaban and Merck recently joined fores with Portola to develop betrixaban.

Microsoft MSFT $24.68 -0.01 0.04% 55,640,970 NASDAQ-GS: NYT B1 "A Hired Gun for Microsfot, In Dogged Pursuit of Google" profiles Qi Lu who for nearly a decade played a key role in building Yahoo's Internet search and advertising technologies. He left Yahoo 14 months ago to lead the charge against Google for MSFT.

NYT pB4 "Challenging Microsoft With a New Technology" says MSFT's No. rival is Google, but a strong candidate for No. 2 is VMware becasue it could potentially undermine the dominance of MSFT's most lucrative products, desktop software andoeprating systems. VMware is the leader in so called virtual machinesoftware, which allows a coputer to run two or mroe operating systems at once. Its software resides on top of the hardware and beneath the opeating system.

IBD pA5, "SAP Is Company At Crossroads As Huge Rivals Line Its Horizon" says Oracle, IBM and MSFT have aggressively built big platforms to attach SAP's market. Story says SAP may eventually be sold to a company such as IBM or MSFT.

Pfizer PFE $16.81 -0.05 0.3% 33,384,351 NYSE: WSJ pB2 "New Blood thinner Matches Warfarin" says a blood thinner being developed by Boehringer Ingleheim GmbH proved to be at lest as effective as the workhorse heart drug warfarin in a trial est that could help usher in a new era for stroke prevention for patients with atrial fibrillation. There are other companies trying to develop an altenative to warfarin which is marketed by Bristol-Myers Squibb as Coumadin and available in generic vesions. JNJ and Bayer's Xarelto is trying to find an product to rival warfarin; Bristol-Myers and Pfizer are codeveloping apixaban and Merck recently joined fores with Portola to develop betrixaban.

Procter & Gamble PG $53.19 +0.13 0.25% 8,948,196 NYSE: WSJ pB4 "Advertising - Hearst Signs On in Beauty Contest - New site Aims to Attract Ads From Cosmetics, Hair-Care Firms" says Hearst hopes a new Web site will pull in advertisers. There is such a website now called Allure that features PG's brands such as herbal Essences hair care line.

MMM $71.92 +0.29 0.4% 3,488,085 NYSE

TRV $49.61 +0.41 0.83% 3,810,917 NYSE

UTX $59.64 -0.37 0.62% 3,835,157 NYSE

Verizon VZ $31.02 -0.03 0.1% 13,760,684 NYSE: NYT pB5, "Newsday Rejects Ads By Verizon, ow a Rival" says that Newsday has turned away VZ, a steady, lucrative customer that is also a direct competitor of the paper's parent company, Cablevision.

WMT $51.13 -0.11 0.21% 14,768,415 NYSE

Here are the latest SEC filings as of 8/24/09 other than ownership filings and, except for certain cases, I do not include third party shareholder proposals:

Symbol & Co. Name/Date of Filing/Form Filed/ Comments

T AT&T 8/17/09 8K annoucning a settlement with he Int'l Communications Works (IBEW) for a 3 year contract covering 8.900 employees in Illinois and Indiana subject to members' approval.
AA Alcoa 7/13/09 8K 2nd Quarter Earnings Results
AXP 8/17/09 8K furnishing owned and managed basis delinquency and write-off statistics for the lending portfolio of its U.S. Card Services (“USCS”) operating segment for the months ended May 31, June 30 and July 31, 2009.
BAC Bank of Am in addition to two 424 Prospectuses and a free writing prospectus regarding issuance of notes, on 8/21/09 8K BAC appointed Robert W. Scully to its board of directors and he is expected to serve on the Asset Quality and Compensation and Benefits Committees of the Board.
BA Boeing 7/28/09 8K On July 28, 2009, BA issued $750,000,000 in aggregate principal amount of 3.500% Senior Notes due 2015, $750,000,000 in aggregate principal amount of 4.875% Senior Notes due 2020 and $450,000,000 in aggregate principal amount of 5.875% Senior Notes due 2040.
CAT Caterpiller 8/20/09 8K CAT filed Reg FD information concerning deliveries to users for its Machinery and Engines lines of business.
CVX Chevron 8/5/09 10Q
CSCO Cisco 8/5/09 8K CSCO reported its results of operations for its fiscal fourth quarter and fiscal year 2009 ended July 25, 2009.
KO Coke 7/30/09 10Q
DIS Disney 7/30/09 10Q
DD DuPont 8/13/09 8K On 8/11/09 DD named Nicholas C. Fanandakis, age 53, Senior Vice President & Chief Financial Officer & Chief Executive effective September 1, 2009 with an increase in annual salary from $387,708 to $500,000 and target short-term incentive award for 2009 will increase from $328,500 to $464,100. Mr. Fanandakis was named to his current position, Group Vice President- Applied BioSciences, in January 2008. Prior to that, he was vice president and general manager- DuPont Chemical Solutions Enterprise from September 2003 through September 2006 and vice president- Corporate Plans from October 2006 through December 2007. Jeffrey L. Keefer, EVP and Chief Financial Officer, will remain EVP and transition from the position of Chief Financial Officer to assume leadership responsibility for the Company’s Performance Coatings business, corporate strategy development, Information Technology and overall cost and working capital productivity efforts effective November 1, 2009.
Richard R. Goodmanson, EVP and Chief Operating Officer has elected to retire from the Company effective September 30, 2009.
XOM Exxon 8/5/09 10Q
GE 8/4/09 8K GE reached a settlement with the SEC & consented to a judgment of a fine of $50 million relating to four accounting matters arising in 2002 - 2003: the application of SFAS 133 to GE’s since-discontinued commercial paper hedging program and, separately, to certain swap derivatives where fees were paid or received at inception; a change in accounting for profits on spare parts in the commercial aviation engine business; and certain year-end transactions in the Rail business.
HPQ Hewlett-Pack 8/18/09 8K re: release of 731/09 3Q results
HD Home Depot 8/18/09 8K re: release of July 31, 2009 3Q results & 8/21 Form ASR automatic shelf registration for debt securities
INTC Intel 8/3/09 10Q
IBM 7/28/09 10Q
JPM JPMorgan 8/25/09 Free Writing Prospectus relating to reverse convertible securities
JNJ Johnson 8/4/09 10Q
KFT Kraft 8/5/09 10Q
MCD McDonalds 8/11/09 re: press release "McDonald’s Reports Global Comparable Sales Up 4.3% in July"
MRK Merck 8/3/09 Sched 14A proxy material re: updated of acquisition of Schering-Plough
MSFT Microsoft 68/24/09 Securities to be offered to employees in employee benefit plans
PFE Pfizer 8/6/09 10Q
PG Procter Gam 8/25/09 424 Prospectus re: Notes due 2015
MMM 3M 8/5/09 3M contributed 8,329,862 shares of its common stock with a corresponding dollar value of approximately $600 million to its defined benefit pension plan, the 3M Employee Retirement Income Plan, made from treasury stock.
TRV Travelers 8/5/09 10Q/A Amended 10Q
UTX United Tech 7/24/09 10Q
VZ Verizon 7/30/09 10Q
WMT Wal-Mart 8/13/09 8K re 7/31/09 2Q report of earnings 0Q

Here are the CEOs of the Dow 30 Companies:

T Randall L. Stephenson
AA Klaus Kleinfeld
AXP Kenneth I. Chenault
BAC Kenneth D. Lewis
BA W. James McNerney, Jr.
CAT James W. Owens
CVX David O'Reilly
CSCO John Chambers
KO Muhtar Kent
DIS Rogert Iger
DD Nicholas C. Fanandakis replaces Ellen Kullman 9/1/09
XOM Rex W. Tillerson
GE Jeffrey R. Immelt
HPQ Mark Hurd
HD Frank Blake
INTC Paul S. Otellini
IBM Samuel J. Palmisano
JPM Jamie Dimon
JNJ William C. Weldon
KFT Irene Rosenfeld
MCD Jim Skinner
MRK Robert Clark
MSFT Steve Ballmer
PFE Jeffrey Kindler
PG Bob McDonald
MMM George W. Buckley
TRV Jay S. Fishman
UTX Louis Chenevert
VZ Ivan Seidenberg
WMT Mike Duke